Aspirin and clopidogrel resistance: methodological challenges and opportunities.
Antiplatelet drug resistance is one of the urgent issues in current cardiovascular medicine. Many platelet function tests have been used to define responsiveness of patients with cardiovascular disease to aspirin and clopidogrel. In most studies, cut-off values of platelet function tests for defining responsiveness to antiplatelets were chosen arbitrarily. Different tests provided wide-ranging figures of the prevalence of aspirin and clopidogrel resistance, suggesting poor correlation between currently available platelet function tests. Measurement of platelet size seems to be a promising approach for monitoring antiplatelet drug therapy. This commentary highlights some limitations of studies on aspirin and clopidogrel resistance in patients undergoing coronary interventions.
Gasparyan
Armen Yuri
AY
Clinical Research Unit, Russell's Hall Hospital, Dudley Group of Hospitals NHS Foundation Trust, West Midlands, UK. a.gasparyan@gmail.com
D001241:Aspirin / Q000627:therapeutic use*; D001792:Blood Platelets / Q000187:drug effects; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D000077144:Clopidogrel; D004351:Drug Resistance; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D010979:Platelet Function Tests; D013988:Ticlopidine / Q000031:analogs & derivatives* / Q000627:therapeutic use
D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine; D001241:Aspirin
Eur Heart J. 2008 Dec;29(23):2877-85
18826988
Acta Haematol. 1999;101(3):140-4
10352333
Eur Heart J. 2007 Jul;28(14):1673-5
17586540
Blood Coagul Fibrinolysis. 2009 Dec;20(8):686-93
19730245
Eur Heart J. 2007 Jul;28(14):1702-8
17569678
Thorac Cardiovasc Surg. 2009 Aug;57(5):281-5
19629890
J Interv Cardiol. 2006 Dec;19(6):507-9
17107365
Stroke. 2006 Aug;37(8):2153-8
16794200
BMJ. 2002 Jan 12;324(7329):71-86
11786451
J Am Coll Cardiol. 2008 May 13;51(19):1829-43
18466797
J Transl Med. 2008 Aug 29;6:46
18759978
J Am Coll Cardiol. 2003 Mar 19;41(6):961-5
12651041
Vasc Health Risk Manag. 2009;5:965-72
19997577
Eur J Cardiothorac Surg. 2008 Jul;34(1):93-108
18448350
Thromb Res. 2009 May;124(1):46-51
19041120
Am Heart J. 2007 Aug;154(2):221-31
17643570
J Thromb Haemost. 2007 Mar;5(3):507-11
17319905
Lancet. 2008 Apr 19;371(9621):1353-63
18377975
Thromb Res. 2010 May;125(5):406-12
19786298